In summary, Nrf2 has demonstrated interesting effects in age-related diseases (Figure 2) and a promise pharmacological target for PD patients, since many studies show a consistent role of this transcriptional factor to modulate for delaying the disease progression. This evidence concerns the gene NFE2L2 and Parkinson disease.